MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

NCT00122226 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
HIV-Associated Lipodystrophy Syndrome

Interventions

DRUG: Lopinavir/ritonavir + zidovudine + lamivudine
DRUG: Lopinavir/ritonavir + nevirapine

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]
[object Object]